Nicholas Hall’s Global Cough, Cold and Allergy report takes an in-depth look at this cornerstone category, offering detailed analysis of key brands as well as individual subcategories. Featuring year-end 2014 sales data from Nicholas Hall’s global OTC database, DB6, this report offers the most up-to-date picture of the current CCA market.
This report covers all major subcategories and profiles 15 countries featuring key trends, regulatory developments and insight into success factors behind leading segments and brands. For OTC marketers looking to continue to build for the future, the report offers sales forecasts to both 2019 and 2024, while also predicting industry prospects as well as opportunities and threats that may impact individual markets.
Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Poland, Russia, Turkey, UK, USA
Key questions addressed:
What are the prospects for key US allergy switches Flonase, Nasacort and Rhinocort? Can this market sustain growth in the face of growing saturation and PL competition?
Which markets are enjoying the best CCA growth, and what are the trends behind the rise?
What opportunities remain untapped?
How has marketing changed to reflect consumer needs, and which brands’ A+P campaigns brought the most dynamism?
Which innovations are having the biggest impact, and what product enhancements are on the horizon?
Global CCA Overview
A snapshot of the global CCA environment including consumer trends and a region by region breakdown
Leading CCA Markets
15 countries profiled featuring key trends, individual category analysis, regulatory developments, success factors behind leading segments and brands, and forecasts for the future
Brand Case Studies
Looking at some of the biggest and most impressive CCA brands and key switches of recent years, including Allegra, Flonase, Mucinex, Nasacort and Vicks, and the factors behind their success
Global CCA Outlook
Predicting the future prospects for the global CCA industry and opportunities & threats in individual markets, including sales forecasts to 2019 and 2024